Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Influence of Early Postoperative Basal Insulin Treatment and Post-Transplant Diabetes Mellitus Risk on Health-Related Quality of Life in Kidney Transplant Recipients-An Analysis of Data From a Randomized Controlled Trial.
Odler B, Huemer M, Schwaiger E, Borenich A, Kurnikowski A, Krall M, Hafner-Giessauf H, Eleftheriadis G, Bachmann F, Faura A, José Pérez-Sáez M, Pascual J, Budde K, Rosenkranz AR, Hecking M, Eller K. Odler B, et al. Among authors: schwaiger e. Transpl Int. 2023 Aug 3;36:11370. doi: 10.3389/ti.2023.11370. eCollection 2023. Transpl Int. 2023. PMID: 37600749 Free PMC article. Clinical Trial.
Empagliflozin in posttransplantation diabetes mellitus: A prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety.
Schwaiger E, Burghart L, Signorini L, Ristl R, Kopecky C, Tura A, Pacini G, Wrba T, Antlanger M, Schmaldienst S, Werzowa J, Säemann MD, Hecking M. Schwaiger E, et al. Am J Transplant. 2019 Mar;19(3):907-919. doi: 10.1111/ajt.15223. Epub 2019 Jan 25. Am J Transplant. 2019. PMID: 30585690 Free PMC article.
Early Postoperative Basal Insulin Therapy versus Standard of Care for the Prevention of Diabetes Mellitus after Kidney Transplantation: A Multicenter Randomized Trial.
Schwaiger E, Krenn S, Kurnikowski A, Bergfeld L, Pérez-Sáez MJ, Frey A, Topitz D, Bergmann M, Hödlmoser S, Bachmann F, Halleck F, Kron S, Hafner-Giessauf H, Eller K, Rosenkranz AR, Crespo M, Faura A, Tura A, Song PXK, Port FK, Pascual J, Budde K, Ristl R, Werzowa J, Hecking M. Schwaiger E, et al. J Am Soc Nephrol. 2021 Aug;32(8):2083-2098. doi: 10.1681/ASN.2021010127. J Am Soc Nephrol. 2021. PMID: 34330770 Free PMC article. Clinical Trial.
Country-specific sex disparities in living kidney donation.
Kurnikowski A, Krenn S, Lewandowski MJ, Schwaiger E, Tong A, Jager KJ, Carrero JJ, Hecking M, Hödlmoser S. Kurnikowski A, et al. Among authors: schwaiger e. Nephrol Dial Transplant. 2022 Feb 25;37(3):595-598. doi: 10.1093/ndt/gfab305. Nephrol Dial Transplant. 2022. PMID: 34669961 Free PMC article. No abstract available.
Combined sodium glucose co-transporter-2 inhibitor and angiotensin-converting enzyme inhibition upregulates the renin-angiotensin system in chronic kidney disease with type 2 diabetes: Results of a randomized, double-blind, placebo-controlled exploratory trial.
Antlanger M, Domenig O, Kaltenecker CC, Kovarik JJ, Rathkolb V, Müller MM, Schwaiger E, Hecking M, Poglitsch M, Säemann MD, Kopecky C. Antlanger M, et al. Among authors: schwaiger e. Diabetes Obes Metab. 2022 May;24(5):816-826. doi: 10.1111/dom.14639. Epub 2022 Jan 24. Diabetes Obes Metab. 2022. PMID: 34984822 Free PMC article. Clinical Trial.
42 results